Optimization and standardization of an enzyme-linked immunosorbent assay protocol for serodiagnosis of Actinobacillus pleuropneumoniae serotype 5.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMC 264994)

Published in J Clin Microbiol on January 01, 1992

Authors

Y L Trottier1, P F Wright, S Larivière

Author Affiliations

1: Groupe de Recherches sur les Maladies Infectieuses du Porc, Faculté de Médecine Vétérinaire, Université de Montréal, Saint Hyacinthe, Quebec, Canada.

Articles cited by this

Haemophilus pleuropneumoniae infection in swine: a review. J Am Vet Med Assoc (1983) 4.57

Pleuropneumonia of swine caused by Haemophilus parahaemolyticus. Studies on the protection obtained by vaccination. Nord Vet Med (1976) 2.52

Porcine Haemophilus pleuropneumonia epizootic in southwestern Ontario: clinical, microbiological, pathological and some epidemiological findings. Can J Comp Med (1981) 2.46

Serotype specificity and immunogenicity of the capsular polymer of Haemophilus pleuropneumoniae serotype 5. Infect Immun (1987) 1.94

Serological characterization of Actinobacillus pleuropneumoniae strains and proposal of a new serotype: serotype 12. Acta Vet Scand (1986) 1.90

Evaluation of the complement fixation test for the diagnosis of pleuropneumonia of swine caused by Haemophilus pleuropneumoniae. Can J Comp Med (1982) 1.67

Role of magnesium in the enzyme-linked immunosorbent assay for lipopolysaccharides of rough Escherichia coli strain J5 and Neisseria gonorrhoeae. J Infect Dis (1980) 1.64

Isolation and biological characterization of two lipopolysaccharides and a capsular-enriched polysaccharide preparation from Haemophilus pleuropneumoniae. Am J Vet Res (1986) 1.58

Immune responses to the lipopolysaccharides and capsular polysaccharides of Haemophilus pleuropneumoniae in convalescent and immunized pigs. Infect Immun (1986) 1.50

Evaluation of different antigens in the complement-fixation test for diagnosis of Haemophilus pleuropneumoniae (parahaemolyticus) infections in swine. Am J Vet Res (1979) 1.45

An enzyme-linked immunosorbent assay, using an EDTA-extracted antigen for the serology of Haemophilus pleuropneumoniae. Am J Vet Res (1981) 1.42

Analysis of major antigens of Haemophilus (Actinobacillus) pleuropneumoniae and related organisms. Infect Immun (1987) 1.38

Epidemiology of Haemophilus pleuropneumoniae infection in pigs: a survey of Ontario Pork Producers, 1981. Can J Comp Med (1983) 1.36

A computer-interfaced photometer and systematic spacing of duplicates to control within-plate enzyme-immunoassay variation. J Immunol Methods (1983) 1.32

Antibody response of swine to outer membrane components of Haemophilus pleuropneumoniae during infection. Infect Immun (1986) 1.23

Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine. Infect Immun (1986) 1.22

Serology of Haemophilus (Actinobacillus) pleuropneumoniae serotype 5 strains: establishment of subtypes a and b. Acta Vet Scand (1986) 1.21

Enzyme immunoassay: observations on aspects of quality control. Vet Immunol Immunopathol (1987) 1.16

The Use of an Enzyme-linked Immunosorbent Assay for Diagnosis of Actinobacillus pleuropneumoniae Infection in Pigs. Can Vet J (1988) 1.16

Detection of serotype-specific antibodies or capsular antigen of Actinobacillus pleuropneumoniae by a double-label radioimmunoassay. J Clin Microbiol (1990) 1.15

[On hemophilosis of the pig. IV. Complement deviation, a test for the detection of Haemophilus parahaemolyticus infections]. Schweiz Arch Tierheilkd (1971) 1.12

Capsular polysaccharide antigens for detection of serotype-specific antibodies to Actinobacillus pleuropneumoniae. Can J Vet Res (1990) 1.12

Prevention and Control of Actinobacillus (Haemophilus) pleuropneumoniae Infection in Swine: A review. Can Vet J (1988) 1.10

Application of a timing protocol to the reduction of inter-plate variability in the indirect enzyme immunoassay for detection of anti-Brucella antibody. J Immunoassay (1985) 1.04

Serodiagnosis of pleuropneumonia using enzyme-linked immunosorbent assay with capsular polysaccharide antigens of Actinobacillus pleuropneumoniae serotypes 1, 2, 5 and 7. Can J Vet Res (1990) 0.95

Structural studies of the O-chains of the lipopolysaccharides produced by strains of Actinobacillus (Haemophilus) pleuropneumoniae serotype 5. Biochem Cell Biol (1990) 0.87

Comparison between radioimmunoassay and direct and indirect enzyme-linked immunosorbent assays for determination of antibodies against Haemophilus influenzae type b capsular polysaccharide. J Clin Microbiol (1988) 0.87

Mortality in swine herds endemically infected with Haemophilus pleuropneumoniae: effect of immunization with cross-reacting lipopolysaccharide core antigens of Escherichia coli. Am J Vet Res (1986) 0.78

The suitability of different microtitre plates for detection of antibody to virus antigens by indirect ELISA. J Biol Stand (1989) 0.77

Articles by these authors

(truncated to the top 100)

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06

The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med (2000) 8.46

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr (2000) 4.08

Primary respiratory syncytial virus infection in mice. J Med Virol (1988) 3.77

Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest (1991) 3.71

Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol (1971) 3.33

Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis (1992) 3.07

Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infect Immun (1982) 2.61

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis (1994) 2.52

Canine kidney cell line for isolation of respiratory viruses. J Clin Microbiol (1979) 2.25

Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old. J Infect Dis (1997) 2.12

Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol (1986) 2.09

Comparison of competitive and indirect enzyme-linked immunosorbent assays for detection of bluetongue virus antibodies in serum and whole blood. J Clin Microbiol (1987) 2.07

Pathological and microbiological observations made on spontaneous cases of acute neonatal calf diarrhea. Can J Comp Med (1976) 2.03

Identification and serotyping of Haemophilus pleuropneumoniae by coagglutination test. J Clin Microbiol (1983) 2.02

From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration. Summary of clinical trials of influenza vaccines--II. J Infect Dis (1976) 1.98

Differing virulence of H1N1 and H3N2 influenza strains. Am J Epidemiol (1980) 1.97

Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis (1986) 1.97

Temperature-sensitive mutants of respiratory syncytial virus. J Virol (1969) 1.94

Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J (2001) 1.90

Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J Med Virol (1985) 1.88

Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. J Infect Dis (1997) 1.86

The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr (2000) 1.85

A comparative study of the rabbit and pig gut loop systems for the assay of Escherichia coli enterotoxin. Can J Comp Med (1972) 1.82

A 2-mercaptoethanol tube agglutination test for diagnosis of Haemophilus pleuropneumoniae infection in pigs. Am J Vet Res (1984) 1.78

Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis (1994) 1.78

Adenovirus infections in young children. Pediatrics (1985) 1.76

Changing presentation of herpes simplex virus infection in neonates. J Infect Dis (1988) 1.76

A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J Infect Dis (1995) 1.68

Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. J Infect Dis (1993) 1.67

Cytomegalovirus pneumonia in two infants recently adopted from China. Clin Infect Dis (1999) 1.65

The natural history of human immunodeficiency virus 1 infection in Haitian infants. Pediatr Infect Dis J (1999) 1.64

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. J Infect Dis (1998) 1.64

Cold-adapted recombinant influenza A virus vaccines in seronegative young children. J Infect Dis (1982) 1.61

Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children. Infect Immun (1982) 1.61

Development of subtype-specific and heterosubtypic antibodies to the influenza A virus hemagglutinin after primary infection in children. J Clin Microbiol (1985) 1.59

Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. J Infect Dis (1988) 1.52

Twenty years of outpatient respiratory syncytial virus infection: a framework for vaccine efficacy trials. Pediatrics (1997) 1.51

Temperature-sensitive mutants of respiratory syncytial virus: in-vivo studies in hamsters. J Infect Dis (1970) 1.51

Detection of genes for fimbrial antigens and enterotoxins associated with Escherichia coli serogroups isolated from pigs with diarrhea. J Clin Microbiol (1991) 1.48

Comparison of influenza B/Hong Kong virus infections among infants, children, and young adults. J Infect Dis (1980) 1.47

Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group. J Infect Dis (1998) 1.47

Safety and antigenicity of influenza A/Hong Kong/68-ts-1 (E) (H3N2). J Pediatr (1975) 1.45

Evaluation of a Killed Vaccine Against Porcine Pleuropneumonia Due to Haemophilus pleuropneumoniae. Can Vet J (1985) 1.44

Serological characterization of Actinobacillus pleuropneumoniae strains isolated from pigs in Quebec. Vet Microbiol (1992) 1.43

Candidate AIDS vaccines. N Engl J Med (1995) 1.41

Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells. J Infect Dis (1983) 1.41

Neonatal diarrhea of pigs in Quebec: infectious causes of significant outbreaks. Can J Comp Med (1983) 1.41

Reinfection of mice with respiratory syncytial virus. J Med Virol (1991) 1.39

Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children. Vaccine (1999) 1.37

Genetic studies of respiratory syncytial virus temperature-sensitive mutants. Arch Gesamte Virusforsch (1973) 1.36

A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. J Infect Dis (1995) 1.36

Influenza A infections in young children. Primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity. N Engl J Med (1977) 1.32

Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants. J Pediatr (1976) 1.31

Growth of influenza A virus in primary, differentiated epithelial cells derived from adenoids. J Virol (1996) 1.29

Pathogenicity of Escherichia coli O115:K"V165" strains isolated from pigs with diarrhea. Am J Vet Res (1989) 1.27

Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity. J Infect Dis (1977) 1.26

Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network. J Infect Dis (1992) 1.25

Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection. J Clin Microbiol (1986) 1.22

Virulence properties of enterotoxigenic Escherichia coli O8: KX105 strains isolated from diarrheic piglets. Infect Immun (1988) 1.22

Respiratory syncytial virus infection in anti-mu-treated mice. J Virol (1991) 1.20

Humoral and cellular immune responses of seronegative children vaccinated with a cold-adapted influenza A/HK/123/77 (H1N1) recombinant virus. Infect Immun (1980) 1.19

Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. J Infect Dis (1996) 1.19

Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators Group. J Infect Dis (1996) 1.16

Electron microscopic studies of respiratory syncytial temperature-sensitive mutants. Arch Gesamte Virusforsch (1973) 1.16

New fimbrial antigen F165 from Escherichia coli serogroup O115 strains isolated from piglets with diarrhea. Infect Immun (1986) 1.16

Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines. Rev Infect Dis (1981) 1.15

Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory. Infect Immun (1983) 1.14

Detection of Actinobacillus pleuropneumoniae in the porcine upper respiratory tract as a complement to serological tests. Can J Vet Res (1993) 1.14

Age-related response to two Haemophilus influenzae type b vaccines. J Pediatr (1982) 1.14

Detection of type-specific antigens in the lungs of Haemophilus pleuropneumoniae-infected pigs by coagglutination test. J Clin Microbiol (1983) 1.13

Immune correlates of protection against influenza in the human challenge model. Dev Biol (Basel) (2003) 1.13

Role of respiratory tract proteases in infectivity of influenza A virus. J Infect Dis (1987) 1.13

Evaluation of the safety of amantadine-HC1 and the role of respiratory viral infections in children with cystic fibrosis. J Infect Dis (1976) 1.12

Evaluation of a temperature-sensitive mutant of respiratory syncytial virus in adults. J Infect Dis (1971) 1.12

A toxigenic profile of Aeromonas hydrophila and Aeromonas sobria isolated from fish. Can J Microbiol (1981) 1.12

A colorimetric microtiter plate PCR system detects respiratory syncytial virus in nasal aspirates and discriminates subtypes A and B. Diagn Microbiol Infect Dis (1999) 1.11

A comparison of five serological tests for bovine brucellosis. Can J Vet Res (1986) 1.10

Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults. Vaccine (2000) 1.07

Prevalence of fimbrial antigens and enterotoxins in nonclassical serogroups of Escherichia coli isolated from newborn pigs with diarrhea. Am J Vet Res (1988) 1.05

Aprotinin and similar protease inhibitors as drugs against influenza. Antiviral Res (2011) 1.05

Escherichia coli strains isolated from diarrheic piglets in the Province of Quebec. Can J Comp Med (1976) 1.04

Application of a timing protocol to the reduction of inter-plate variability in the indirect enzyme immunoassay for detection of anti-Brucella antibody. J Immunoassay (1985) 1.04

Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants. Vaccine (1999) 1.04

Lack of comparability between commonly used serological assays of immune response to Haemophilus influenzae vaccine. J Infect Dis (1987) 1.04

Eustachian tube histopathology during experimental influenza A virus infection in the chinchilla. Ann Otol Rhinol Laryngol (1987) 1.03

Production and purification of heat-stable enterotoxin b from a porcine Escherichia coli strain. Infect Immun (1991) 1.03

An outbreak of airborne nosocomial varicella. Pediatrics (1982) 1.03

Evaluation of various methods for the detection of enteropathogenic Escherichia coli in diarrheic calves. Am J Vet Res (1979) 1.02

Ureaplasma urealyticum polyarthritis in agammaglobulinemia. Pediatr Infect Dis (1986) 1.02

Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response. Vaccine (1997) 1.01

Development and evaluation of an indirect enzyme immunoassay for detection of porcine antibodies to pseudorabies virus. Can J Vet Res (1986) 1.01

A review of enzyme immunoassay for detection of antibody to Brucella abortus in cattle. Vet Immunol Immunopathol (1988) 1.01

Management of genital herpes simplex virus infection occurring during pregnancy. Am J Obstet Gynecol (1981) 1.01

Clinical studies of pneumococcal vaccines in infants. II. Efficacy and effect on nasopharyngeal carriage. Rev Infect Dis (1981) 1.00

Clinical implications of preseptal (periorbital) cellulitis in childhood. Pediatrics (1978) 1.00

An evaluation of agglutination and coagglutination techniques for serotyping of Haemophilus pleuropneumoniae isolates. Am J Vet Res (1987) 0.99

The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation. FEMS Immunol Med Microbiol (1999) 0.99

Different virulence of influenza A virus strains and susceptibility to pneumococcal otitis media in chinchillas. Infect Immun (1983) 0.99

Antibody-dependent cell-mediated cytotoxicity against cells infected with respiratory syncytial virus: characterization of in vitro and in vivo properties. J Immunol (1979) 0.98